Medtronic Inc. received FDA clearance of the Reveal DX Insertable Cardiac Monitor (ICM) designed to help physicians identify the cause of unexplained fainting or abnormal heart rhythms, including ventricular tachyarrhythmias (VT), fast ventricular tachyarrhythmias (FVT), bradyarrhythmias and asystole.
When cardiologists send their high-risk patients home, they may be protected with a host of tools, including implantable cardiac devices and pacemakers and strict regimens of medications. While the tools and regimens are powerful, cardiologists know that they are still limited when it comes to preventing adverse events. Without constant check-ups, serious coronary issues can occur.
February 5, 2008 - Premera Blue Cross has revised its Corporate Medical Policy to make Microvolt T-Wave Alternans ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The Sentinel by Spacelabs reportedly integrates an entire range of noninvasive diagnostic cardiology solutions including ...
February 5, 2008 - The Medical Imaging & Technology Alliance (MITA), a division of NEMA, said today that the budget ...
A new 320-slice computed tomography (CT) system, the AquilionONE by Toshiba America Medical Systems, delivers dynamic ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The HeartStation ECG management system automates the processing and storage of electrocardiograms to reportedly improve ...
Delivering vivid and insightful CT images of the coronary vessels directly into the cardiac catheterization laboratories (cath labs) has proven very effective by helping save staff from re-acquiring images of the heart and boosting patient throughput. But CT images are only part of the bigger picture.
February 5, 2008 - The FAMILION test for Long QT Syndrome (LQTS) has met the Blue Cross and Blue Shield Association ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
CardioDynamics recently received market clearance from the FDA for its BioZ Impedance Cardiography (ICG) clinical ...
February 5, 2008 – CV Therapeutics Inc. and Medlogics Device Corp. entered into an agreement under which Medlogics has ...
The latest version of GE’s MUSE 7.0 system reportedly incorporates enhancements in information technology, ECG management processes and clinical report editing in an all-digital environment for paperless workflow.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Advanced Integrated IVUS Technology
Fluke Biomedical's product line of defibrillator and pacemaker analyzer technologies includes the Impulse 6000D ...
February 4, 2008 - The Centers for Medicare & Medicaid Services (CMS) announced that after completing a review of its 1986 national non-coverage policy for artificial hearts, its preliminary decision is to provide reimbursement for patients who receive the CardioWest temporary Total Artificial Heart (TAH-t) as part of FDA studies that meet CMS specifications.